![Christopher Frankenfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Frankenfield
Directeur Financier/CFO chez
XILIO THERAPEUTICS, INC.
Fortune : 14 966 $ au 31/05/2026
Profil
Mr. Christopher Frankenfield is a Chief Operating & Financial Officer at Xilio Therapeutics, Inc. Mr. Frankenfield was previously employed as a Vice President-Corporate & Legal Affairs by Blueprint Medicines Corp.
and a Senior Associate by Wilmer Cutler Pickering Hale & Dorr LLP.
He received his undergraduate degree from The College of William & Mary and a graduate degree from the University of Virginia School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XILIO THERAPEUTICS INC 0,03 % | 02/01/2026 | 1 769 ( 0,03 % ) | 14 966 $ | 31/05/2026 |
Postes actifs de Christopher Frankenfield
| Sociétés | Poste | Début |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Directeur Financier/CFO | 08/08/2024 |
Anciens postes connus de Christopher Frankenfield
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Conseiller Juridique Général | 01/03/2021 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Formation de Christopher Frankenfield
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Choisissez Zonebourse 
